INTRODUCTION
Clinically important changes in serum complement levels are associated with the acute phase response (1); several acquired diseases in which complement consumption, as well as synthesis, are presumably altered (2, 3) ; and genetic deficiencies of the complement proteins (4) . Studies of the mechanisms accounting for these changes have been hampered by limited access to liver biopsy material. As early as 1900 Ehrlich and Morgenroth (5) suggested that complement was synthesized in the liver, and recently it was established that liver is the primary, if not the sole source of several serum complement components (reviewed in 6). After Dr. Aden is the recipient of a Research Career Development Award from the American Cancer Society, CA00510.
Received for publication 13 April 1982. orthotopic liver transplantation from donors with distinct genetic variants of individual serum complement proteins, complete conversion from recipient to donor allotype was noted. This means that the liver is the source of at least 90% of the C3, C6, C8, and factor B contained in serum. Further support for the thesis that the liver is a site of complement synthesis was obtained in studies of primary cultures of human fetal and adult liver (mixed cell type and tissue slices) (7) and in several rat hepatoma cell strains (8) .
On the other hand, considerable data indicating extrahepatic complement synthesis have been accumulated. Macrophages and monocytes synthesize Cl, C2, C3, C4, C5, and factor B (reviewed in 9); fibroblasts synthesize Cl and C3 (10, 11) ; and epithelial cells produce Cl (12) . It is probable that these cells are important for local complement production, though not as sources of complement in serum. There is direct evidence for structural, and possibly functional, differences between fibroblast Clq and the corresponding serum complement protein (13) . For other components, notably C2 and C4, changes in local complement production by alveolar and peritoneal macrophages can be induced without affecting serum levels (14) . Nonetheless, studies of complement production by monocytes and fibroblasts have been useful for initial investigations of human genetic disorders of complement production. Interpretation of these results has been limited by the fact that complement of extrahepatic origin contributes little to serum levels (6) .
In the guinea pig (15, 16) and the mouse (17, 18) there is evidence that several multichain complement proteins are synthesized as single-chain precursor proteins. For the corresponding human complement proteins, the availability of a hepatoma-derived cell line HepG2 (19) permitted a similar analysis of the precursor, human pro-C3. That work established that human serum C3 is synthesized as a single-chain pre-cursor protein, which is converted by limited proteolysis to native functional C3 (20) . The present study was undertaken to ascertain whether this well differentiated human hepatoma, HepG2, is suitable for studies of the biosynthesis of other human complement -proteins and to investigate the details of their translation, posttranslational processing, and secretion. 10 mM sodium phosphate; 150 mM NaCl; 10 mM EDTA; 2 mM phenyl methyl sulfonic fluoride, pH 7.6; and a freezethaw cycle. After centrifugation for 30 min at 15,000 g, the supernatant fluids were removed and frozen at -70°in 1-ml aliquots until use. TCA-precipitable protein in the media and lysates was determined as described (24) .
METHODS
Assay of medium for complement function. For assay of the functional activity of each component, a dilution of culture medium was made in isotonic veronal-buffered saline (VBS) sucrose with gelatin, calcium, and magnesium, pH 7.35 (VBS sucrose) for Cl, Clq, Clr, Cls, C4, C2, and Cl inhibitor (INH) and in VBS with dextrose, magnesium, calcium, and gelatin, pH 7.35 (VBS-dextrose) for C3, C5, C6, C7, C8, C9, and B. Assays for Cl, C2, C4, and Cl INH components were done essentially as outlined by Rapp and Borsos (25) and for C3 as modified by Colten et al. (26) and factor B by Beatty et al. (27) . Clq, Clr, and Cls assays were adapted from the Cl assay (25) using purified Cl subcomponents and EA as indicator cells for Clq and EAC1q4 for Clr and Cls assays. Effective molecules (Eff Mol) of each component were calculated by the method outlined by Rapp and Borsos (25) . These assays are capable of detecting <100 pg/ml of functional complement components with an error of ±5%. The efficiency of the hemolytic assays for serum C3, C2, and C4 were estimated. The efficiency of detection was 1% for C3, 3.1% for C2, and 73% for C4. These values agree with those previously published for C2 and C4 (28) and C3 (29) .
To determine if newly synthesized C3 is cleaved by C3b inactivator in a manner analogous to serum C3 (30) , and to assay for inactivator function in conditioned medium, the following experiment was done. The amount of protein in cellular lysates and culture media was estimated by absorbance 2 of dilutions of each. C3b was produced by treatment of media and lysates with L-1-tosylamide-2-phenylethylchloromethyl ketone-trypsin. Aliquots of medium or lysate with a known protein concentration were brought to 22°C and then an amount of L-1-tosylamide-2-phenylethylchloromethyl ketone-trypsin (1 mg/ml) was added to equal 1% of the total protein in the lysate or medium. After 3 min at 22°C the trypsin was inactivated by addition of a twofold excess of soybean trypsin inhibitor. After centrifugation for 5 min at 15,000 g, aliquots of the trypsin-treated and untreated media and lysates were transferred to 1.5 ml Beckman centrifuge tubes (Beckman Instruments, Inc., Spinco Div., Palo Alto, CA). Enough purified C3b inactivator, alone, or with ,BIH were added so that the concentration of each was equivalent to 5% of the protein content of the lysates or media. These were vortexed and incubated for 2 h at 37°C. C3 was then precipitated from each sample and analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) (31) as described.
Immunoprecipitation of complement components from medium and intracellular lysates. Cellular lysates and culture medium (made 2 mM in phenyl methyl sulfonic fluoride with a 200-mM phenyl methyl sulfonic fluoride stock in absolute ethanol, 0.5% in Triton X-100 and deoxycholate using 2.5% Triton X-100, 2.5% deoxycholate, 10 mM sodium phosphate, 150 mM NaCl, pH 7.6; and 10 mM in EDTA with a 200-mM pH 7.6 stock) were centrifuged at 15,000 g for 5 min before measured aliquots were removed to new tubes.
For precipitations using purified proteins as carrier, an amount of antibody was added to the lysates or media to yield a twofold antibody excess and an amount of antigen to yield 30 gg of protein in the precipitate at equivalence.
Mixtures were incubated for 1.5 h at room temperature if the total volume was <200 gl, and 3 h for volumes to 800 ,ul. The immune precipitates were washed three times in 0.5% Triton X-100, 0.5% deoxycholate, 10 mM sodium phosphate, 150 mM NaCI, 10 mM EDTA, pH 7.6; once in 150 mM NaCI, and once in acetone. The acetone was removed in vacuo and the pellets were dissolved in Laemmli sample buffer (31) (Fig. 1) . Cl, Clq, C7, and C9 were not detected at 6 or 96 h, but a small amount of functional C8 was present at 96 h. Net pro- (Fig. 3A-E, left-hand  panels) . Analysis of long-term cultures indicated that if the media were not changed throughout the 96-h period, functional activity of C2 and C4 decreased at later time periods (Fig. 3A-E, right-hand panels) . Recovery of functional C3 plateaued at 72-96 h. Only C5 and B function were unaffected by the sampling procedure. The possibility was considered that the instability of C2, and C4 or apparent lack of or low synthesis of C6, C7, and C9 was the result of degradation. Purified C4, C6, C7, and C9 were added to 96-h sampled culture media (conditioned medium) and incubated at 37°C for 24 h. C4 activity decreased but C6, C7, and C9 were stable (data not shown).
Isolation of complement proteins from cellular lysates and culture medium. SDS-PAGE analysis under reducing conditions of immunoprecipitates of CS, C4, and C5 showed radiolabeled bands at -180,000, 190,000, and 180,000 daltons, respectively in intracellular lysates (Fig. 4) . The corresponding extracellular complement proteins in the me( and subunit structures that were identic and C5 purified from serum i.e., th bands comigrated with the polypeptide dium had sizes teins isolated from plasma. Intracellular factor B had ,al with C3, C4, an apparent mol wt of 89,000; slightly less than the ke radiolabeled extracellular protein (92,000) (Fig. 4) . Control ims from the pro-munoprecipitates subjected to the same analysis showed a band at 22,000 daltons but no labeled proteins with mobilities of the intra-or extracellular complement proteins.
Precursor-product relationship between pro-C4 and C4, pro-C5 and C5, intracellular and extracellular B and intracellular and extracellular C2. To determine whether the intracellular single-chain C4 and C5 antigens were authentic precursors of the corresponding multichain proteins, a pulse-chase experiment was performed, the results of which are shown in Figs. 5 and 6. Similarly, the rates of factor B and C2 secretion were also obtained from this experiment (Figs. 7 and  8 ). After incubation of the cells for 30 min with medium containing L-[35S]methionine, labeled pro-C4 -to -I I 12 (Fig. 5) , pro-C5 (Fig. 6), intracellular B (Fig. 7) , and he human hepa-intracellular C2 (Fig. 8) were detected in the cellular liogram of SDS-lysates. During the chase period, the gradual disap-> of C3, C4, C5, pearance of each was accompanied by the appearance goat serum (con-extracellularly of the native three-chain C4, two-chain :or S h with 250 C5, and factor B and C2. The rate of factor B secretion -methionine-free was similar to that of C2 secretion (Fig. 7 vs. Fig. 8 ). The rate of secretion of functional C2 exceeded the rate of factor B secretion by 5-10-fold. This is similar to the relative rates of secretion of these structurally and functionally analogous proteins in the human alveolar and breast milk macrophages (14) . In contrast, the human peripheral blood monocyte secretes about equal amounts of C2 and factor B even after prolonged culture in vitro (14) . The detection of functional and immunochemical Cls was particularly important because C2 and C4, the natural substrates of the Cls enzyme, were unstable in cultures maintained for 96 h without a medium change. Nevertheless, it was possible in short-term cultures (4-6 h), to estimate rates of secretion of functional C2 and C4, and, by introducing a complete medium change at 24-h intervals, to study secretion over a 4-d period. From the immunochemical evidence some C4 breakdown can be deduced by noting a' chain of C4b in medium at 360 min after a pulse-chase (Fig. 5) . Thus the secretion rate calculated from net accumulation of active C4 and C2 must be considered a minimal estimate. Factor B and C5 continued to accumulate in culture media at approximately linear rates, whereas CS levels plateaued after 48 h in culture. This effect was observed in cultures from which small aliquots were removed for complement assays (i.e., when spent medium was not replaced completely with fresh medium at regular intervals). The reasons for different patterns of net accumulation of individual proteins is not known but the effect in each instance was abrogated by removing the medium at 24-h intervals and refeeding with fresh media.
In studies of the cell-free translation of guinea pig mRNA, a putative single chain precursor of native guinea pig C4 (pro-C4) was identified (15) . Gorski and Muller Eberhard (32) and independently, Gigli (33) detected a similar protein in normal human plasma and suggested that perhaps this was human pro-C4. Formal proof of the precursor product relationship between single chain pro-C4 and C4 has been provided for the corresponding guinea pig (15) and mouse proteins (17) but not for human pro-C4. In addition, in experimental animals (34, 35) a precursor of native C5 (pro-C5) was identified; but heretofore, human pro-C5 had not been described. Pulse-chase experiments with the HepG2 cells establish that human pro-C4, pro-C5 and pro-CS (20) are authentic precursors of the corresponding multichain complement proteins. In guinea pig macrophage cultures C2 and factor B each undergo a two-step glycosylation sequence which results in recovery of a slightly smaller molecular weight protein intracellularly than is found in serum or extracellular medium (36) . Th, data reported here suggest a similar postsynthetic process for human C2 and factor B. An additional cell-associated C2 protein was found in detergent lysates of HepG2. This protein, in contrast to the precursor of extracellular C2 proteins, failed to disappear from the cell compartment during a chase with unlabeled amino acids. This finding is similar to the report of membrane associated factor B found in mouse macrophages (37) . The role of these cell associated complement proteins remains to be established.
Altogether, these data demonstrate the utility of the HepG2 cell line for studies of the biosynthesis, posttranslational modification, and secretion of most of the proteins of the complement system.
